These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 20829888)

  • 1. Preliminary survey of educational support for patients prescribed ocular hypotensive therapy.
    Gray TA; Fenerty C; Harper R; Lee A; Spencer AF; Campbell M; Henson DB; Waterman H
    Eye (Lond); 2010 Dec; 24(12):1777-86. PubMed ID: 20829888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors for poor adherence to eyedrops in electronically monitored patients with glaucoma.
    Friedman DS; Okeke CO; Jampel HD; Ying GS; Plyler RJ; Jiang Y; Quigley HA
    Ophthalmology; 2009 Jun; 116(6):1097-105. PubMed ID: 19376591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intentional and unintentional nonadherence to ocular hypotensive treatment in patients with glaucoma.
    Rees G; Leong O; Crowston JG; Lamoureux EL
    Ophthalmology; 2010 May; 117(5):903-8. PubMed ID: 20153902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comprehensive perspective on patient adherence to topical glaucoma therapy.
    Tsai JC
    Ophthalmology; 2009 Nov; 116(11 Suppl):S30-6. PubMed ID: 19837258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of eye drop administration technique in patients with glaucoma or ocular hypertension.
    Schwartz GF; Hollander DA; Williams JM
    Curr Med Res Opin; 2013 Nov; 29(11):1515-22. PubMed ID: 24006861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Level of adherence to ocular hypotensive agents and its determinant factors among glaucoma patients in Menelik II Referral Hospital, Ethiopia.
    Mehari T; Giorgis AT; Shibeshi W
    BMC Ophthalmol; 2016 Aug; 16():131. PubMed ID: 27485739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measurement of adherence to brimonidine therapy for glaucoma using electronic monitoring.
    Hermann MM; Bron AM; Creuzot-Garcher CP; Diestelhorst M
    J Glaucoma; 2011 Oct; 20(8):502-8. PubMed ID: 20852438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IOP-lowering efficacy and tolerability of preservative-free tafluprost 0.0015% among patients with ocular hypertension or glaucoma.
    Hommer A; Mohammed Ramez O; Burchert M; Kimmich F
    Curr Med Res Opin; 2010 Aug; 26(8):1905-13. PubMed ID: 20553122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Doctor-patient communication, health-related beliefs, and adherence in glaucoma results from the Glaucoma Adherence and Persistency Study.
    Friedman DS; Hahn SR; Gelb L; Tan J; Shah SN; Kim EE; Zimmerman TJ; Quigley HA
    Ophthalmology; 2008 Aug; 115(8):1320-7, 1327.e1-3. PubMed ID: 18321582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adherence with topical glaucoma medication monitored electronically the Travatan Dosing Aid study.
    Okeke CO; Quigley HA; Jampel HD; Ying GS; Plyler RJ; Jiang Y; Friedman DS
    Ophthalmology; 2009 Feb; 116(2):191-9. PubMed ID: 19084273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Doctor-patient communication in glaucoma care: analysis of videotaped encounters in community-based office practice.
    Friedman DS; Hahn SR; Quigley HA; Kotak S; Kim E; Onofrey M; Eagan C; Mardekian J
    Ophthalmology; 2009 Dec; 116(12):2277-85.e1-3. PubMed ID: 19744715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence and correlates of self-reported nonadherence with eye drop treatment: the Belgian Compliance Study in Ophthalmology (BCSO).
    Vandenbroeck S; De Geest S; Dobbels F; Fieuws S; Stalmans I; Zeyen T
    J Glaucoma; 2011 Sep; 20(7):414-21. PubMed ID: 21048510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preservative-free tafluprost 0.0015% in the treatment of patients with glaucoma and ocular hypertension.
    Erb C; Lanzl I; Seidova SF; Kimmich F
    Adv Ther; 2011 Jul; 28(7):575-85. PubMed ID: 21725844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Barriers to adherence with glaucoma medications: a qualitative research study.
    Lacey J; Cate H; Broadway DC
    Eye (Lond); 2009 Apr; 23(4):924-32. PubMed ID: 18437182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Morning dosing of once-daily glaucoma medication is more convenient and may lead to greater adherence than evening dosing.
    Ford BA; Gooi M; Carlsson A; Crichton AC
    J Glaucoma; 2013 Jan; 22(1):1-4. PubMed ID: 21946541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adherence to glaucoma medication: the effect of interventions and association with personality type.
    Lim MC; Watnik MR; Imson KR; Porter SM; Granier AM
    J Glaucoma; 2013 Aug; 22(6):439-46. PubMed ID: 22411021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Using pharmacy claims data to study adherence to glaucoma medications: methodology and findings of the Glaucoma Adherence and Persistency Study (GAPS).
    Friedman DS; Quigley HA; Gelb L; Tan J; Margolis J; Shah SN; Kim EE; Zimmerman T; Hahn SR
    Invest Ophthalmol Vis Sci; 2007 Nov; 48(11):5052-7. PubMed ID: 17962457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patient Experience during the Support, Educate, Empower Glaucoma Coaching Program to Improve Medication Adherence: A Pilot Study.
    Hollenhorst CN; Elliott V; Heisler M; Schneider K; Resnicow K; Newman-Casey PA
    Ophthalmol Glaucoma; 2020; 3(4):238-252. PubMed ID: 33008556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Programs to optimize adherence in glaucoma.
    Kowing D; Messer D; Slagle S; Wasik A;
    Optometry; 2010 Jul; 81(7):339-50. PubMed ID: 20630372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The clinical validity of the treatment satisfaction survey for intraocular pressure in ocular hypertensive and glaucoma patients.
    Day DG; Sharpe ED; Atkinson MJ; Stewart JA; Stewart WC
    Eye (Lond); 2006 May; 20(5):583-90. PubMed ID: 15933751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.